Method of genetic correction of sickle cell anemia through recombination of homologues in embryonic stem cells
- Authors: Bersenev A.V.
- Issue: Vol 1, No 3 (2006)
- Pages: 18-19
- Section: Cell technology
- URL: https://genescells.ru/2313-1829/article/view/256168
- DOI: https://doi.org/10.23868/gc256168
- ID: 256168
Cite item
Open Access
Access granted
Full Text
About the authors
A. V. Bersenev
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation
References
- Pawliuk R., Westerman K.A., Fabry M.E. et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 2001; 294: 2368-71.
- Puthenveetil G., Scholes J., Carbonell D. et al. Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood 2004; 104: 3445-53.
- Rideout W.M., Hochedlinger K., Kyba M. et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 2002; 109: 17-27.
Supplementary files
